New advances in the management of acute coronary syndromes: 1. Matching treatment to risk

CMAJ. Canadian Medical Association Journal

Volumn 164, Issue 9, 2001, Pages 1309-1316

  Fitchett, D ^a   Goodman, S ^a   Langer, A ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; TROPONIN I;

BLOOD PRESSURE; CLINICAL FEATURE; CORONARY ARTERY; CORONARY ARTERY COLLATERAL CIRCULATION; DIABETES MELLITUS; DISEASE COURSE; ELECTROCARDIOGRAM; EMERGENCY WARD; ENZYME BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HOSPITAL; HOSPITAL MANAGEMENT; HUMAN; HYPERCHOLESTEROLEMIA; PHYSICAL EXAMINATION; PHYSICIAN; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; SYMPTOMATOLOGY; T WAVE; TREATMENT OUTCOME;

EID: 0034922925     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Coronary bypass surgery for unstable angina
2. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
3. Electrocardiographic and clinical criteria for the recognition of acute myocardial infarction based on analysis of 3,697 patients
4. Clinical features of unrecognized myocardial infarction - Silent and symptomatic. Eighteen year follow-up: The Framingham study
5. Incidence and prognosis of unrecognized myocardial infarction: An update on the Framingham study
6. Clinically unrecognized myocardial infarction in the Western Collaborative Group Study
7. Missed diagnoses of acute myocardial infarction in the emergency department: Results from a multi-center study
8. A combined approach using multiple myocardial markers predicts adverse events among ED patients
9. Prognostic value of the admission electrocardiogram in acute coronary syndromes
10. Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (A Thrombin Inhibition in Myocardial Ischemia [TRIM] substudy)
11. Patients with suspected myocardial infarction who present with ST depression
12. Metaanalysis in clinical chemistry: Validation of cardiac troponin T as a marker for ischemic heart diseases
13. Angiographic findings in patients with refractory unstable angina according to troponin T status
14. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes
15. Cardiac troponin T levels for risk stratification in acute myocardial ischemia
16. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes
17. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction
18. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I
19. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban
20. Predictors of risk in patients with unstable angina admitted to a district general hospital
21. Acute coronary syndromes in the GUSTO-IIb trial: Prognostic insights and impact of recurrent ischemia
22. ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction
23. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making
24. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients
25. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
26. Guidelines for the early management of acute coronary syndromes: Focus on antithrombotic and antiplatelet therapy
27. Aspirin, heparin, or both to treat acute unstable angina
28. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia
29. Low-molecular-weight heparin during instability in coronary artery disease
30. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
31. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial
32. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
33. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
34. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
35. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
36. Results of the Treat angina with Aggrastat and determine the Cost of Therapy with an Invasive or Conservative Strategy (TACTICS-TIMI 18) Trial. A comparison of invasive and conservative strategy in patients with unstable angina and non-ST-segment elevation myocardial infarction
37. Clopidogrel in unstable angina to prevent recurrent events
38. A clinical trial of a chest-pain observation unit for patients with unstable angina